ENDRA Life Sciences Inc.
(NASDAQ : NDRA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.43%198.231.2%$509.44m
GILDGilead Sciences, Inc.
-0.04%73.560.9%$446.87m
BIIBBiogen Inc.
-0.26%330.101.3%$367.66m
CELGCelgene Corporation
0.07%82.641.2%$330.69m
ILMNIllumina, Inc.
-1.44%317.053.5%$286.26m
REGNRegeneron Pharmaceuticals, Inc.
-1.44%378.632.6%$220.72m
ALXNAlexion Pharmaceuticals, Inc.
0.62%122.702.0%$210.04m
VRTXVertex Pharmaceuticals Incorporated
-1.24%179.071.9%$200.96m
SRPTSarepta Therapeutics, Inc.
0.49%131.1416.4%$167.24m
AAgilent Technologies, Inc.
-0.12%66.161.5%$154.36m
BMRNBioMarin Pharmaceutical Inc.
0.91%100.424.4%$129.52m
LGNDLigand Pharmaceuticals Incorporated
-0.51%201.5623.3%$107.59m
VKTXViking Therapeutics, Inc.
-2.35%14.120.9%$106.20m
NKTRNektar Therapeutics
0.27%49.045.6%$105.75m
NBIXNeurocrine Biosciences, Inc.
-0.70%110.705.1%$96.30m

Company Profile

ENDRA Life Sciences, Inc. engages in the development of ultrasound technology for the pre-clinical research market. Its products include Photo-Acoustic Nexus-128 system, which screens and modifies disease models, and Thermo-Acoustic Enhanced UltraSound, which will enable clinicians to visualize human tissue composition, function, and temperature. The company was founded in 2007 and is headquartered in Ann Arbor, MI.